SEC Company Response from NOVARTIS AG (NVS, NVSEF) (CIK 0001114448) (NVS) — Jun 16, 2011
NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)
Date: June 16, 2011 · CIK: 0001114448 · Accession: 0001104659-11-035111
AI Filing Summary & Sentiment
File numbers found in text: 001-15024
Referenced dates: April 22, 2011
Letter
Form 20-F for Fiscal Year Ended December 31, 2010 Filed January 27, 2011 File No. 001-15024
Re: Novartis AG
Dear Mr. Rosenberg:
We are in receipt of your letter addressed to Jonathan Symonds, our Chief Financial Officer, dated June 2, 2011, which was in response to our letter dated April 22, 2011. As agreed in a June 14, 2011 telephone call between Thomas Werlen, our General Counsel, and Frank Wyman, Staff Accountant at SEC, our time to respond to your letter is extended through and including June 30, 2011.
Respectfully submitted,
Novartis AG
Show Raw Text
CORRESP 1 filename1.htm Novartis AG Postfach 4002 Basel Switzerland June 15, 2011 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant US Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Novartis AG Form 20-F for Fiscal Year Ended December 31, 2010 Filed January 27, 2011 File No. 001-15024 Dear Mr. Rosenberg: We are in receipt of your letter addressed to Jonathan Symonds, our Chief Financial Officer, dated June 2, 2011, which was in response to our letter dated April 22, 2011. As agreed in a June 14, 2011 telephone call between Thomas Werlen, our General Counsel, and Frank Wyman, Staff Accountant at SEC, our time to respond to your letter is extended through and including June 30, 2011. Respectfully submitted, Novartis AG /s/ JONATHAN SYMONDS /s/ THOMAS WERLEN Jonathan Symonds Thomas Werlen Chief Financial Officer General Counsel Novartis Group Novartis Group